PRTA Q1 2026 Earnings EPS Surges 27169 Above Estimates Despite No Revenue Stock Edges Lower TScan Therapeutics Q1 2026 Earnings Narrowing Loss Despite EPS Miss Stock Gains on Pipeline Progress QUAD Q1 2026 Earnings EPS Beat Underpins Cost Discipline Stock Edges Higher WHLRL Q2 2024 Earnings Bondholder EPS Surprises Revenue Unreported Red Violet RDVT Q1 2026 Earnings Strong EPS Beat Drives Stock Higher RPT Q1 2026 Earnings Significant EPS Miss as Company Reports Negative Earnings